Jane Street’s Amplify Treatments, Testing and Advancements ETF GERM Stock Holding History

Jane Street’s Portfolio GERM Stock Details GERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,851	Closed	-$265K	–	10259
2022 Q4	$265K	Buy	+11,851	New	+$267K	﹤0.01%	7229
2022 Q1	–	Sell	-10,992	Closed	-$392K	–	11255
2021 Q4	$392K	Buy	10,992 +5,624	+105%	+$211K	﹤0.01%	7687
2021 Q3	$220K	Sell	5,368 -2,355	-30%	-$99.4K	﹤0.01%	8712
2021 Q2	$309K	Sell	7,723 -42,586	-85%	-$1.59M	﹤0.01%	8095
2021 Q1	$1.78M	Buy	+50,309	New	+$1.89M	﹤0.01%	4235
2020 Q4	–	Sell	-26,843	Closed	-$742K	–	8287
2020 Q3	$742K	Buy	+26,843	New	+$789K	﹤0.01%	4570

Other funds holding GERM

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GBWM

Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

BAM

Belpointe Asset Management Reno, Nevada $2.74B AUM 20.71% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street's GERM Position: Q1 2023 in Review

Jane Street sold out of Amplify Treatments, Testing and Advancements ETF (GERM) in Q1 2023, closing a stake of 11,851 shares — an estimated $265K sold.

Jane Street first reported a position in GERM in Q3 2020 and held it in 6 quarters. The position peaked at $1.78M in Q1 2021. 19 funds tracked by Wall St. Rank hold GERM as of Q1 2023.

Jane Street reported no remaining Amplify Treatments, Testing and Advancements ETF position as of Q1 2023 after selling out during the quarter.
Jane Street sold 11,851 Amplify Treatments, Testing and Advancements ETF shares in Q1 2023, an estimated $265K.
Jane Street first reported a position in Amplify Treatments, Testing and Advancements ETF in Q3 2020 and held it in 6 quarters.
Jane Street's Amplify Treatments, Testing and Advancements ETF position peaked at $1.78M in Q1 2021.
19 funds tracked by Wall St. Rank held Amplify Treatments, Testing and Advancements ETF as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.